NEW YORK, April 2 - Proteomics company Zyomyx said today that it has been granted a second patent by the US Patent and Trademark Office for its protein-chip technology.
The patent, which was granted today, covers surface chemistry configurations and describes a variety of antibody arrays.
In January, the company secured a related patent on protein-chip surface and attachment technology.
Based in Hayward, Calif., Zyomyx is developing high density protein biochips based on a surface chemistry derived from high resolution microscopy. The company, which is privately owned, hopes to develop chips for up to 10,000 different proteins.